×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CATX – perspective therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CATX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/13
08:03 am
catx
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $14.00 price target on the stock.
Low
Report
Perspective Therapeutics (NASDAQ:CATX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $14.00 price target on the stock.
1/12
07:00 am
catx
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference
High
Report
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference
1/9
07:00 am
catx
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium
Low
Report
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium
12/18
07:00 am
catx
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/4
07:00 am
catx
Perspective Therapeutics Announces Acceptance of VMT-a-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium
High
Report
Perspective Therapeutics Announces Acceptance of VMT-a-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium
11/24
11:00 am
catx
Perspective Therapeutics (NASDAQ:CATX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $12.00 price target on the stock.
Low
Report
Perspective Therapeutics (NASDAQ:CATX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $12.00 price target on the stock.
11/24
08:08 am
catx
Perspective Therapeutics (NASDAQ:CATX) had its price target lowered by analysts at B. Riley from $12.00 to $11.00. They now have a "buy" rating on the stock.
Neutral
Report
Perspective Therapeutics (NASDAQ:CATX) had its price target lowered by analysts at B. Riley from $12.00 to $11.00. They now have a "buy" rating on the stock.
11/24
08:06 am
catx
Perspective Therapeutics (NASDAQ:CATX) had its price target lowered by analysts at UBS Group AG from $18.00 to $7.00. They now have a "buy" rating on the stock.
Neutral
Report
Perspective Therapeutics (NASDAQ:CATX) had its price target lowered by analysts at UBS Group AG from $18.00 to $7.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
04:05 pm
CATX
perspective therapeutics, inc.
MISS
Report
0.0%
perspective therapeutics, inc.
8/13/2025
06:45 am
CATX
perspective therapeutics, inc.
BEAT
Report
-3.8%
perspective therapeutics, inc.
5/12/2025
04:36 pm
CATX
perspective therapeutics, inc.
BEAT
Report
-1.9%
perspective therapeutics, inc.
Date
Time
Symbol
Headline
Impact
1/14
07:01 am
catx
Form 8-K Perspective Therapeutics For: Jan 14
Low
Report
Form 8-K Perspective Therapeutics For: Jan 14
1/12
08:20 am
catx
Form 8-K Perspective Therapeutics For: Jan 12
High
Report
Form 8-K Perspective Therapeutics For: Jan 12
1/9
07:26 am
catx
Form 8-K Perspective Therapeutics For: Jan 09
Low
Report
Form 8-K Perspective Therapeutics For: Jan 09
12/5
02:04 pm
catx
Form SCHEDULE 13G/A Perspective Therapeutics Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Perspective Therapeutics Filed by: FMR LLC
12/1
04:14 pm
catx
Form 8-K Perspective Therapeutics For: Dec 01
Medium
Report
Form 8-K Perspective Therapeutics For: Dec 01
11/17
08:02 am
catx
Form 4 Perspective Therapeutics For: Nov 13 Filed by: Hunt Jonathan Robert
Medium
Report
Form 4 Perspective Therapeutics For: Nov 13 Filed by: Hunt Jonathan Robert
11/14
08:00 am
catx
Form 4 Perspective Therapeutics For: Nov 12 Filed by: Williamson Robert F III
Low
Report
Form 4 Perspective Therapeutics For: Nov 12 Filed by: Williamson Robert F III
11/10
04:23 pm
catx
Form 10-Q Perspective Therapeutics For: Sep 30
Low
Report
Form 10-Q Perspective Therapeutics For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: